Effects of PERK eIF2 alpha Kinase Inhibitor against Toxoplasma gondii

Augusto, L; Martynowicz, J; Staschke, KA; Wek, RC; Sullivan, WJ

Sullivan, WJ (reprint author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.; Sullivan, WJ (reprint author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018; 62 (11):

Abstract

Toxoplasma gondii is an obligate intracellular parasite that has infected one-third of the population. Upon infection of warm-blooded vertebrates, the......

Full Text Link